Lonsdale Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 6.42%
- Profit Growth 33.77%
- Ebitda 33.80%
- Net Worth 13.52%
- Total Assets 17.30%
About Lonsdale Life Sciences
Lonsdale Life Sciences Private Limited (LLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 April 2011 and has a history of 13 years and nine months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Maddireddy Sujatha and Maddireddy Varun serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232TG2011PTC073729
-
Company No.
073729
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Apr 2011
-
Date of AGM
15 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Lonsdale Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maddireddy Sujatha
|
Whole-Time Director | 07-Nov-2011 | Current |
|
Maddireddy Varun
|
Whole-Time Director | 06-Apr-2011 | Current |
Financial Performance of Lonsdale Life Sciences.
Lonsdale Life Sciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.42% increase. The company also saw a substantial improvement in profitability, with a 33.77% increase in profit. The company's net worth Soared by an impressive increase of 13.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lonsdale Life Sciences?
In 2023, Lonsdale Life Sciences had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Cyclic Life Sciences Private LimitedMaddireddy Varun is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lonsdale Life Sciences?
Unlock and access historical data on people associated with Lonsdale Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lonsdale Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lonsdale Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
